journal article·2024-12-27Open access

Imputing Covariance for Meta-Analysis in the Presence of Interaction

Enwu Liu, Ryan Yan Liu

Applied Sciences· Volume 15· Issue 1

Abstract

Detecting interactions is a critical aspect of medical research. When interactions are present, it is essential to calculate confidence intervals for both the main effect and the interaction effect. This requires determining the covariance between the two effects. In a two-stage individual patient data (IPD) meta-analysis, the coefficients, as well as their variances and covariances, can be calculated for each study. These coefficients can then be combined into an overall estimate using either a fixed-effect or random-effects meta-analysis model. The overall variance of the combined coefficient is typically derived using the inverse-variance method. The most commonly used method for calculating the overall covariance between the main effect and the interaction effect in meta-analysis is multivariate meta-analysis. In this paper, we propose an alternative, straightforward, and transparent method for calculating this covariance when interactions are considered in a meta-analysis. To facilitate implementation, we have developed an R package, ‘covmeta’.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Meta-analysis and systematic reviews

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia

References (27)

Show source-provided references
1. A meta-analysis of previous falls and subsequent fracture risk in cohort studies10.1007/s00198-023-07012-1 ↗
2. Previous fracture and subsequent fracture risk: A meta-analysis to update FRAX10.1007/s00198-023-06870-z ↗
3. Two-stage vs. one-stage meta-analysis10.1016/j.ajodo.2024.06.003 ↗
4. Two-stage or not two-stage? That is the question for IPD meta-analysis projects10.1002/jrsm.1661 ↗
5. Confidence interval estimation for the changepoint of treatment stratification in the presence of a qualitative covariate-treatment interaction10.1002/sim.8404 ↗
6. Multivariate meta-analysis of multiple outcomes: Characteristics and predictors of borrowing of strength from Cochrane reviews10.1186/s13643-022-01999-0 ↗
7. Basten, M., van Tuijl, L.A., Pan, K.Y., Hoogendoorn, A.W., Lamers, F., Ranchor, A.V., Dekker, J., Frank, P., Galenkamp, H., and Knol, M.J. (2024). Estimating additive interaction in two-stage individual participant data meta-analysis. Am. J. Epidemiol., kwae325.10.1093/aje/kwae325 ↗
8. Sauerbrei, W., and Royston, P. (2022). Investigating treatment-effect modification by a continuous covariate in IPD meta-analysis: An approach using fractional polynomials. BMC Med. Res. Methodol., 22.10.1186/s12874-022-01516-w ↗
9. Khan, S. (2020). Meta-Analysis Methods for Health and Experimental Studies, Springer.10.1007/978-981-15-5032-4 ↗
10. Borenstein, M., Hedges, L.V., Higgins, J.P., and Rothstein, H.R. (2021). Introduction to Meta-Analysis, John Wiley & Sons.10.1002/9781119558378 ↗
11. Schwarzer, G., and James, R. (2015). Carpenter, Gerta Rucke. Meta-Analysis with R, Springer.10.1007/978-3-319-21416-0 ↗
12. Methods for estimating between-study variance and overall effect in meta-analysis of odds ratios10.1002/jrsm.1404 ↗
13. Dufour, J.-M. (2024, December 20). Covariance, Correlation and Linear Regression Between Random Variables. 2024. Available online: https://www2.cirano.qc.ca/~dufourj/Web_Site/ResE/ECON763_2024W/Dufour_2016_C_Covariances_W_Slides.pdf.
14. Schwarzer, G. (2022). Meta-Analysis in R. Systematic Reviews in Health Research: Meta-Analysis in Context, John Wiley & Sons.10.1002/9781119099369.ch26 ↗
15. Chen, D.-G.D., and Peace, K.E. (2021). Multivariate Meta-Analysis. Applied Meta-Analysis with R and Stata, Chapman and Hall/CRC.
16. Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: Statistical recommendations for conduct and planning10.1002/sim.8516 ↗
17. Understanding of interaction (subgroup) analysis in clinical trials10.1111/eci.13145 ↗
18. Statistical Considerations for Subgroup Analyses10.1016/j.jtho.2020.12.008 ↗
19. Interpretation of subgroup analyses in systematic reviews: A tutorial10.1016/j.cegh.2018.05.005 ↗
20. Higgins, J.P.T., López-López, J.A., and Aloe, A.M. (2020). Meta-regression. Handbook of Meta-Analysis, Chapman and Hall/CRC.10.1201/9781315119403-7 ↗
21. Problems and pitfalls in subgroup analysis and meta-regression10.1016/j.ajodo.2020.09.001 ↗
22. The lack of statistical power of subgroup analyses in meta-analyses: A cautionary note10.1017/S2045796021000664 ↗
23. (2024, November 28). The Stata News, In the Spotlight: Multivariate Meta-Analysis. Available online: https://www.stata.com/stata-news/news37-1/multivariate-meta-analysis/.
24. Riley, R.D., Jackson, D., and White, I.R. (2021). Multivariate Meta-Analysis Using IPD. Individual Participant Data Meta-Analysis: A Handbook for Healthcare Research, John Wiley & Sons.10.1002/9781119333784.ch13 ↗
25. Meta-analyses of partial correlations are biased: Detection and solutions10.1002/jrsm.1704 ↗
26. Wu, D., Goldfeld, K.S., and Petkova, E. (2023). Developing a Bayesian hierarchical model for a prospective individual patient data meta-analysis with continuous monitoring. BMC Med. Res. Methodol., 23.10.1186/s12874-022-01813-4 ↗
27. Geissbühler, M., Hincapié, C.A., Aghlmandi, S., Zwahlen, M., Jüni, P., and da Costa, B.R. (2021). Most published meta-regression analyses based on aggregate data suffer from methodological pitfalls: A meta-epidemiological study. BMC Med. Res. Methodol., 21.10.1186/s12874-021-01310-0 ↗